Old Web
English
Sign In
Acemap
>
authorDetail
>
Melody B. Zhang
Melody B. Zhang
Stanford University
Immunology
Minimal residual disease
Medicine
Population
Transplantation
4
Papers
2
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Universal Minimal Residual Disease Quantification Using Consensus Primers and High-Throughput Igh Sequencing Predicts Post-Transplant Cll Relapse Better Than Patient-Specific PCR
2012
Biology of Blood and Marrow Transplantation
Aaron C Logan
Melody B. Zhang
Malek Faham
Victoria Carlton
Jianbiao Zheng
Martin Moorhead
Tom Willis
Carol Jones
Amna Waqar
James L. Zehnder
David B. Miklos
Show All
Source
Cite
Save
Citations (0)
Massively Parallel Immunoglobulin Gene Sequencing Provides Ultra-Sensitive Minimal Residual Disease Detection and Predicts Post-Transplant Relapse in Acute Lymphoblastic Leukemia by Three to Six Months,
2011
Blood
Aaron C Logan
Nikita Vashi
Malek Faham
Victoria Carlton
Ismael Buño
Jianbiao Zheng
Martin Moorhead
Mark Klinger
Tom Willis
Melody B. Zhang
Amna Waqar
James L. Zehnder
David B. Miklos
Show All
Source
Cite
Save
Citations (0)
High-Throughput Immunoglobulin Gene Sequencing Quantifies Minimal Residual Disease in CLL with 10e-6 Sensitivity and Strongly Predicts Relapse After Allogeneic Hematopoietic Cell Transplantation
2011
Blood
Aaron C Logan
Malek Faham
Victoria Carlton
Jianbiao Zheng
Martin Moorhead
Tom Willis
Carol Jones
Melody B. Zhang
Amna Waqar
James L. Zehnder
David B. Miklos
Show All
Source
Cite
Save
Citations (2)
Temozolomide In Acute Myeloid Leukemia: A MGMT Promoter Methylation Status–Based Treatment Stratification
2010
Blood
Bruno C. Medeiros
Holbrook Kohrt
Richa Rajwanshi
Jason Gotlib
Steven Coutre
Michaela Liedtke
Caroline Berube
Melody B. Zhang
Daniel A. Arber
James L. Zehnder
Show All
Source
Cite
Save
Citations (0)
1